BioLife4D

BioLife4D

Early Stage

Build a Heart. Save a life.

Build a Heart. Save a life.

Overview

Raised this Round: Raised: $275,333

Total Commitments ($USD)

Platform

Dalmore Group

Start Date

10/22/2020

Close Date

Not Provided

Min. Goal
$1,080
Max. Goal
$46,133,806
Min. Investment

$1,080

Security Type

Equity - Common

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$13.50

Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Location

Buffalo Grove, Illinois

BioLife4D is raising funds on Dalmore Group through Reg A+ crowdfunding. The company aims to use the current advances in cardiac tissue engineering to build human hearts suitable for implantation. The company will use 3D bioprinting to make patient-specific hearts using the patients’ own cells. The hearts of BioLife4D will have a precise fit and a perfect genetic match. BioLife4D has printed a mini-heart and working on a functional mini-heart for toxicity testing. Steven Morris founded BioLife4D in 2016. The current crowdfunding campaign has no minimum target and a maximum target of $46,133,806. The campaign proceeds will be used for marketing, salaries, rent, equipment, licenses, and working capital.

Balance Sheet

Cash and Cash Equivalents

$1,337,468

Total Assets

$1,376,956

Accounts Payable & Accrued Liabilities

$34,077

Long Term Debt

$850,000

Total Liabilities

$978,580

Total Stockholders' Equity

$398,376

Total Liabilities and Equity

$1,376,956

Statement of Comprehensive Income Information

Costs & Expenses Applicable to Rev

$1,504,757

Net Income

$-1,569,796

Earnings Per Share - Basic

$0.00

Earnings Per Share - Diluted

$0.00

Auditor: IndigoSpire
Financials as of: 10/22/2020
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
BioLife4D on Dalmore Group 2020
Platform: Dalmore Group
Security Type: Equity - Common
Price per Share: $13.50

Follow company

Follow BioLife4D on Dalmore Group 2020

Buy BioLife4D's Deal Report

Warning: according to the close date for this deal, BioLife4D may no longer be accepting investments.

BioLife4D Deal Report

Get KingsCrowd’s comprehensive report on BioLife4D including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether BioLife4D is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the BioLife4D deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge